Bank of America
ACOR

Bank of America’s Acorda Therapeutics ACOR Stock Holding History

Bank of America’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-51
Closed -$674 – 8594
2024
Q1 		$674 Buy
51
+1
+2% +$15 ﹤0.01% 7252
2023
Q4 		$754 Buy
+50
New +$567 ﹤0.01% 7236
2022
Q4 		– Hold
0
– – – 8557
2022
Q3 		– Hold
0
– – – 8399
2022
Q2 		– Hold
0
– – – 8643
2022
Q1 		– Sell
-1,520
Closed -$59.8K – 9003
2021
Q4 		$73K Buy
1,520
+549
+57% +$37.8K ﹤0.01% 7033
2021
Q3 		$89K Buy
971
+962
+10,689% +$79.8K ﹤0.01% 6786
2021
Q2 		$1K Sell
9
-33
-79% -$2.89K ﹤0.01% 7680
2021
Q1 		$4K Buy
42
+33
+367% +$4.05K ﹤0.01% 7159
2020
Q4 		$1K Sell
9
-6
-40% -$552 ﹤0.01% 7038
2020
Q3 		$1K Sell
15
-566
-97% -$42.7K ﹤0.01% 6814
2020
Q2 		$51K Buy
581
+466
+405% +$49.3K ﹤0.01% 5976
2020
Q1 		$13K Sell
115
-1,129
-91% -$222K ﹤0.01% 6300
2019
Q4 		$304K Buy
1,244
+938
+307% +$237K ﹤0.01% 5355
2019
Q3 		$106K Sell
306
-855
-74% -$465K ﹤0.01% 6016
2019
Q2 		$1.07M Sell
1,161
-613
-35% -$753K ﹤0.01% 4517
2019
Q1 		$2.83M Sell
1,774
-97
-5% -$175K ﹤0.01% 3696
2018
Q4 		$3.5M Sell
1,871
-3,587
-66% -$7.81M ﹤0.01% 3342
2018
Q3 		$12.9M Buy
5,458
+4,689
+610% +$14.5M ﹤0.01% 2225
2018
Q2 		$2.65M Buy
769
+304
+65% +$931K ﹤0.01% 3760
2018
Q1 		$1.32M Sell
465
-75
-14% -$225K ﹤0.01% 4188
2017
Q4 		$1.39M Sell
540
-1,109
-67% -$3.15M ﹤0.01% 4258
2017
Q3 		$4.68M Sell
1,649
-392
-19% -$1.03M ﹤0.01% 3240
2017
Q2 		$4.83M Buy
2,041
+335
+20% +$664K ﹤0.01% 3063
2017
Q1 		$4.3M Buy
1,706
+472
+38% +$1.36M ﹤0.01% 3168
2016
Q4 		$2.79M Sell
1,234
-158
-11% -$376K ﹤0.01% 3484
2016
Q3 		$3.49M Buy
1,392
+130
+10% +$388K ﹤0.01% 3168
2016
Q2 		$3.86M Sell
1,262
-136
-10% -$442K ﹤0.01% 3029
2016
Q1 		$4.44M Buy
1,398
+73
+6% +$303K ﹤0.01% 2877
2015
Q4 		$6.8M Sell
1,325
-907
-41% -$3.96M ﹤0.01% 2628
2015
Q3 		$7.1M Buy
2,232
+306
+16% +$1.19M ﹤0.01% 2530
2015
Q2 		$7.7M Buy
1,926
+412
+27% +$1.59M ﹤0.01% 2176
2015
Q1 		$6.04M Sell
1,514
-201
-12% -$921K ﹤0.01% 2300
2014
Q4 		$8.41M Sell
1,715
-5
-0.3% -$21.5K ﹤0.01% 2067
2014
Q3 		$7M Buy
1,720
+42
+3% +$158K ﹤0.01% 2251
2014
Q2 		$6.79M Sell
1,678
-164
-9% -$669K ﹤0.01% 2270
2014
Q1 		$8.38M Sell
1,842
-256
-12% -$1.03M ﹤0.01% 1921
2013
Q4 		$7.35M Buy
2,098
+132
+7% +$515K ﹤0.01% 2131
2013
Q3 		$8.07M Sell
1,966
-127
-6% -$547K ﹤0.01% 1969
2013
Q2 		$8.29M Buy
+2,093
New +$8.62M ﹤0.01% 1876

Other funds holding ACOR

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of America's ACOR Position: Q2 2024 in Review

Bank of America sold out of Acorda Therapeutics (ACOR) in Q2 2024, closing a stake of 51 shares — an estimated $674 sold.

Bank of America first reported a position in ACOR in Q2 2013 and held it in 37 quarters. The position peaked at $12.9M in Q3 2018. 2 funds tracked by Wall St. Rank hold ACOR as of Q2 2024.

  • Bank of America reported no remaining Acorda Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Bank of America sold 51 Acorda Therapeutics shares in Q2 2024, an estimated $674.
  • Bank of America first reported a position in Acorda Therapeutics in Q2 2013 and held it in 37 quarters.
  • Bank of America's Acorda Therapeutics position peaked at $12.9M in Q3 2018.
  • 2 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2024.

Based on Bank of America's 13F filing for Q2 2024, filed 14 Aug 2024.